Biogen (BIIB) News Today $143.66 -1.65 (-1.14%) Closing price 04:00 PM EasternExtended Trading$144.96 +1.31 (+0.91%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIIB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Wedbush Forecasts Biogen's Q3 Earnings (NASDAQ:BIIB)October 15 at 7:16 AM | marketbeat.comVanguard Personalized Indexing Management LLC Has $4.39 Million Position in Biogen Inc. $BIIBOctober 15 at 4:05 AM | marketbeat.comBiogen (NASDAQ:BIIB) Price Target Raised to $135.00October 14 at 9:24 AM | marketbeat.comAberdeen Group plc Purchases 9,942 Shares of Biogen Inc. $BIIBOctober 14 at 4:03 AM | marketbeat.comLEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025”October 13 at 7:50 PM | financialpost.comFEisai and Biogen's LEQEMBI IQLIK™ Named One of TIME's "Best Inventions of 2025" for Alzheimer's TreatmentOctober 13 at 7:50 PM | quiverquant.comQLEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's “Best Inventions of 2025”October 13 at 7:30 PM | globenewswire.comWhat is William Blair's Estimate for Biogen FY2025 Earnings?October 13 at 2:21 AM | americanbankingnews.comFY2025 Earnings Forecast for Biogen Issued By William BlairOctober 13 at 2:20 AM | marketbeat.comBiogen (BIIB): Revisiting Valuation After Recent Pipeline and Partnership DevelopmentsOctober 12 at 12:25 AM | finance.yahoo.comWhat to Expect From Biogen’s Q3 2025 Earnings ReportOctober 11, 2025 | finance.yahoo.comValeo Financial Advisors LLC Invests $225,000 in Biogen Inc. $BIIBOctober 11, 2025 | marketbeat.com7 Analysts Have This To Say About BiogenOctober 11, 2025 | benzinga.comMorgan Stanley Maintains Biogen (BIIB) Equal-Weight RecommendationOctober 11, 2025 | msn.comLeerink Partnrs Issues Positive Outlook for Biogen EarningsOctober 11, 2025 | americanbankingnews.comBiogen price target raised to $149 from $144 at Morgan StanleyOctober 10, 2025 | msn.comQ3 Earnings Estimate for Biogen Issued By Leerink PartnrsOctober 10, 2025 | marketbeat.comWhat to Expect From Biogen’s Q3 2025 Earnings ReportOctober 10, 2025 | barchart.comQ4 Earnings Forecast for Biogen Issued By Leerink PartnrsOctober 10, 2025 | americanbankingnews.comBiogen (NASDAQ:BIIB) Earns Sell (D+) Rating from Weiss RatingsOctober 9, 2025 | marketbeat.comBiogen and Stoke Therapeutics Announce Positive Long-Term Results of Zorevunersen in Dravet Syndrome at Child Neurology Society Annual MeetingOctober 9, 2025 | quiverquant.comQBiogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet SyndromeOctober 9, 2025 | financialpost.comFBiogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet SyndromeOctober 9, 2025 | globenewswire.comBiogen's Comeback: Why The Bulls Are Finally Winning AgainOctober 9, 2025 | seekingalpha.comSimplicity Wealth LLC Makes New $430,000 Investment in Biogen Inc. $BIIBOctober 9, 2025 | marketbeat.comRoyal Bank Of Canada Lowers Biogen (NASDAQ:BIIB) Price Target to $217.00October 8, 2025 | marketbeat.comLeerink Partnrs Issues Negative Forecast for Biogen EarningsOctober 8, 2025 | marketbeat.comBiogen Inc. $BIIB Shares Purchased by KLP Kapitalforvaltning ASOctober 8, 2025 | marketbeat.comAscent Group LLC Takes $341,000 Position in Biogen Inc. $BIIBOctober 8, 2025 | marketbeat.comBiogen (NASDAQ:BIIB) Stock Price Expected to Rise, Rothschild & Co Redburn Analyst SaysOctober 8, 2025 | americanbankingnews.comEisai, Biogen announce U.S. availability of LEQEMBI IQLIKOctober 7, 2025 | msn.comEisai and Biogen Launch LEQEMBI Companion™ Program to Enhance Resources for Alzheimer's Disease TreatmentOctober 6, 2025 | quiverquant.comQEisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's DiseaseOctober 6, 2025 | prnewswire.comEisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's DiseaseOctober 6, 2025 | globenewswire.comRothschild & Co Redburn Increases Biogen (NASDAQ:BIIB) Price Target to $150.00October 6, 2025 | marketbeat.comGrimes & Company Inc. Sells 18,310 Shares of Biogen Inc. $BIIBOctober 6, 2025 | marketbeat.comMirae Asset Global Investments Co. Ltd. Raises Holdings in Biogen Inc. $BIIBOctober 6, 2025 | marketbeat.comJ. Safra Sarasin Holding AG Sells 7,635 Shares of Biogen Inc. $BIIBOctober 6, 2025 | marketbeat.comIs Global Expansion of LEQEMBI Enough to Reinforce Biogen’s (BIIB) Long-Term Pipeline Strength?October 3, 2025 | finance.yahoo.comBIIB Stock: Is Biogen Still A Buy After The 14% Spike?October 3, 2025 | forbes.comBiogen Inc. $BIIB Shares Sold by Robeco Institutional Asset Management B.V.October 3, 2025 | marketbeat.comGreenleaf Trust Raises Holdings in Biogen Inc. $BIIBOctober 3, 2025 | marketbeat.comJefferies Initiates Coverage on Biogen Inc. (BIIB) with Buy Rating and $190 PTOctober 1, 2025 | insidermonkey.comBiogen (NASDAQ:BIIB) Trading 8.1% Higher - Still a Buy?October 1, 2025 | marketbeat.comGenerali Investments CEE investicni spolecnost a.s. Buys 11,695 Shares of Biogen Inc. $BIIBOctober 1, 2025 | marketbeat.comSignaturefd LLC Has $574,000 Stake in Biogen Inc. $BIIBOctober 1, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Receives Average Rating of "Hold" from BrokeragesSeptember 30, 2025 | marketbeat.comBiogen Inc. $BIIB Stake Raised by Fifth Third BancorpSeptember 29, 2025 | marketbeat.comEisai, Biogen announce LEQEMBI approved by NMPA in ChinaSeptember 29, 2025 | msn.com“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in ChinaSeptember 28, 2025 | financialpost.comF Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BIIB Media Mentions By Week BIIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼0.530.73▲Average Medical News Sentiment BIIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼3630▲BIIB Articles Average Week Get the Latest News and Ratings for BIIB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Biogen and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Amgen News Today Gilead Sciences News Today Ionis Pharmaceuticals News Today Moderna News Today Prothena News Today Cassava Sciences News Today Vertex Pharmaceuticals News Today Bristol Myers Squibb News Today Eli Lilly and Company News Today Pfizer News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
